| Phase 3 |
| NCT04437329 |
Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma |
Nasopharyngeal Carcinoma |
Recruiting |
2022-05-10 |
| NCT06327932 |
HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer |
Non-Muscle-Invasive Bladder Cancer |
Not Yet Recruiting |
2024-03-25 |
| Phase 2 |
| NCT07286240 |
QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian… |
Treatment of Recurrent Ovarian Cancer |
Recruiting |
2025-12-16 |
| NCT07286253 |
QL1706 Plus Chemotherapy as Neoadjuvant Therapy for Locally Advanced Cervical Cancer: A… |
Neoadjuvant Treatment for Locally Advanced Cervical Cancer |
Recruiting |
2025-12-16 |
| NCT04922658 |
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer |
Advanced Non-Small Cell Lung Cancer |
Active, Not Recruiting |
2026-07-15 |
| NCT06594172 |
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After… |
Radiation Disease |
Not Yet Recruiting |
2024-09-19 |
| NCT05648487 |
HIPEC Combined With Sintilimab for Gastric Cancer With Peritoneal Metastasis |
Gastric Cancer |
Not Yet Recruiting |
2022-12-16 |
| NCT05484583 |
Durvalumab Combined With Consolidation Radiotherapy After First-line Treatment in… |
Lung Cancer |
Not Yet Recruiting |
2022-08-05 |
| NCT05484375 |
Capecitabine Plus Toripalimab Maintenance Therapy in Metastatic Nasopharyngeal Carcinoma… |
Metastatic Nasopharyngeal Carcinoma |
Not Yet Recruiting |
2022-08-02 |
| Not specified |
| NCT07602569 |
A Prospective Study on the Diagnosis of Malignant Tumors With 18F-FGIn PET/CT |
Cancer (With or Without Metastasis) |
Recruiting |
2026-05-22 |
| NCT05661110 |
Biomarker Analysis of HIPEC Combined With PD1/PDL1 Inhibitor for Gastric Cancer With… |
Gastric Cancer |
Not Yet Recruiting |
2022-12-22 |